“…Axillary-sparing total mastectomy is a proposed primary management option, unless evident pathologic lymphadenopathy is present [ 3 , 25 ]. Axillary nodes are usually nonpathologic in appearance, as distant hematogenous metastasis is more characteristic, but lymph node metastasis may occur in a few patients [ 6 , [26] , [27] , [28] ]. Unfavorable axillary status has been described as a primary poor prognostic indicator and is considered stage IV disease by the American Joint Committee On Cancer, warranting axillary assessment [ 27 ].…”